Biotricity, Inc. (BTCY)
OTCMKTS
· Delayed Price · Currency is USD
0.325
-0.025 (-7.14%)
Jan 21, 2025, 11:57 AM EST
Biotricity Revenue
Biotricity had revenue of $3.27M in the quarter ending September 30, 2024, with 12.99% growth. This brings the company's revenue in the last twelve months to $12.62M, up 13.55% year-over-year. In the fiscal year ending March 31, 2024, Biotricity had annual revenue of $12.06M with 25.15% growth.
Revenue (ttm)
12.62M
Revenue Growth
+13.55%
P/S Ratio
0.38
Revenue / Employee
229.45K
Employees
55
Market Cap
8.59M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 12.06M | 2.42M | 25.15% |
| Mar 31, 2023 | 9.64M | 1.99M | 26.00% |
| Mar 31, 2022 | 7.65M | 4.27M | 126.02% |
| Mar 31, 2021 | 3.38M | 1.97M | 138.75% |
| Mar 31, 2020 | 1.42M | 1.02M | 256.03% |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.79B |
| Veradigm | 1.53B |
| SS Innovations International | 16.04M |
| Elite Pharmaceuticals | 71.17M |
| Glass House Brands | 188.29M |
| Northwest Biotherapeutics | 1.60M |
| BioStem Technologies | 210.49M |
| Silence Therapeutics | 21.77M |
Biotricity News
- 7 days ago - Biotricity and B-Secur Partner to Launch the Most Comprehensive Device-Neutral Ambulatory Cardiac Monitoring Platform - PRNewsWire
- 26 days ago - Biotricity Produces Largest Inventory in its History to Meet Accelerated Demand - PRNewsWire
- 7 weeks ago - Biotricity achieves positive free cash flow - Seeking Alpha
- 7 weeks ago - Biotricity Achieves Positive Free Cash Flow Milestone - PRNewsWire
- 2 months ago - Biotricity, Inc. (BTCY) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Biotricity GAAP EPS of -$0.07, revenue of $3.3M - Seeking Alpha
- 2 months ago - Biotricity Achieves Improved Margins and Efficiencies, and Year-Over-Year Sales Growth for Second Quarter of Fiscal Year 2025 - GlobeNewsWire
- 2 months ago - Biotricity to Host Second Quarter Fiscal Year 2025 Financial Results and Business Update Call on November 15th - GlobeNewsWire